CP
Carol S. Portlock
Highly rated in
15
conditions
Highly rated in
15
conditions
Check Dr. Carol S. Portlock's experience treating your condition:
About Dr. Carol S. Portlock

Carol Portlock is an Oncologist in New York, New York. Portlock has been practicing medicine for over 51 years and is highly rated in 15 conditions, according to our data. Her top areas of expertise are Non-Hodgkin Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma MZL, and Gastric Lymphoma. She is licensed to treat patients in New York.

Her clinical research consists of co-authoring 48 peer reviewed articles and participating in 4 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Carol S. Portlock it is best to call her office and ask if your insurance is accepted.

Locations
1275 York Ave, New York, NY 10065
Other Locations
1275 York Ave, New York, NY 10065
Background & Education
Graduate Institution
Stanford University School Of Medicine, 1971.0
Specialties
Oncology
Licenses
Internal Medicine in NY
Languages Spoken
English
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

Lenalidomide Therapy In Previously Untreated, Advanced Stage Follicular Lymphoma
A Phase II Study of the Novel Proteasome Inhibitor Bortezomib in Combination With Rituximab, Cyclophosphamide and Prednisone in Patients With Relapsed/Refractory Indolent B-Cell Lymphoproliferative Disorders and Mantle Cell Lymphoma (MCL)
Biaxin(Clarithromycin)Based Antibiotic Therapy In Previously Untreated, Advanced Stage Indolent Lymphoma
View 3 Less Clinical Trials -

48 Total Publications

Involved-site radiotherapy for Helicobacter pylori-independent gastric MALT lymphoma: 26 years of experience with 178 patients.
Summary: Involved-site radiotherapy for Helicobacter pylori-independent gastric MALT lymphoma: 26 years of experience with 178 patients.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors